Cytek Biosciences, Inc. (CTKB)

Market Cap	740.46M
Revenue (ttm)	193.02M
Net Income (ttm)	-12.15M
Shares Out	130.82M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	456,434
Open	5.78
Previous Close	5.81
Day's Range	5.65 - 5.82
52-Week Range	3.80 - 12.31
Beta	1.37
Analysts	Buy
Price Target	9.00 (+59.01%)
Earnings Date	May 7, 2024

About CTKB

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 2021
• Employees: 676
• Stock Exchange: NASDAQ
• Ticker Symbol: CTKB

Analyst Forecast

According to 5 analysts, the average rating for CTKB stock is "Buy." The 12-month stock price forecast is $9.0, which is an increase of 59.01% from the latest price.

Price Target

$9.0

(59.01% upside)

Analyst Consensus: Buy